Logo | Name | Σ | ||
---|---|---|---|---|
CNRS The French National Centre for Scientific Research is among the world's leading research institutions. Its scientists explore the living world, matter, the Universe, and the functioning of human societies in order to meet the major challenges of today and tomorrow. Internationally recognised for the excellence of its scientific research, the CNRS is a reference in the world of research and development, as well as for the general public. Recherche scientifique, Biologie, Chimie, Ecologie et environnement, Ingénierie et systèmes, Mathématiques, Physique, Sciences de l'information, Homme et société, Nucléaire et particules, Terre et Univers, and Science Sectors: Research | 3040 | 2344 | 429 | |
Pôle Véhicule du Futur [Automatic translation follows] Solutions for vehicles & mobility of the future A benchmark competitiveness cluster for vehicles, mobility solutions and associated services, the Vehicle of the Future Cluster brings together and leads an ecosystem of 500 members in the Bourgogne-Franche-Comté and Grand Est regions. As the regional representative of the PFA Filière Automobile & Mobilités, the Cluster is associated with the Strategic Contract of the automotive sector and responds to the major challenges of the evolution of mobility and the industry of the future. It brings together companies, public research structures, training organizations and territories around collaborative innovation projects, industrial … Sectors: French Cluster Public business cluster | 294 | 143 | 151 | |
Novartis Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand, and Gene and cell therapy Sectors: Pharmaceutical | 1763 | 1569 | 123 |